One-hour automated point-of-care sepsis testing. Nucleomics is developing diagnostic tests and life science tools based on a single-molecule RNA-counting platform technology developed in Ulrich Keyser's lab at the University of Cambridge. The test is based on hybridisation and enzyme free.
Company Details
- Employees
- 5
- Address
- Cambridge, Gb
- Industry
- Biotechnology
- Keywords
- Diagnostics, Sepsis, Pathogen detection, RNA.
- HQ
- Cambridge
Cambridge Nucleomics Questions
Cambridge Nucleomics's LinkedIn profile is https://uk.linkedin.com/company/cambridge-nucleomics
Cambridge Nucleomics has
5 employees.
View email and phone details for 5
employees at Cambridge Nucleomics.
Cambridge Nucleomics's industry is
Biotechnology
Cambridge Nucleomics's top competitors are
Cc Bio,
Rxcelerate,
Quotient Therapeutics,
Reachsci,
Rwas | رواس,
Micrographia Bio,
Scindo,
Cycle Therapeutics,
Isogenica,
Uksacb.
Cambridge Nucleomics's categories are Biotechnology
